On ECHEMI
Home > Drugs > Anhu Welman Pharmaceut Icai Cd.ltd
Anhu Welman Pharmaceut Icai Cd.ltd
  • Founded in:

    1992-06-19
  • Country:

    China China
  • Address:

    No. 510, Wangjiang West Road, High-tech Zone, Hefei City, Anhui Province
  • Tax NO.:

    913401006103789162
  • Registered Funds:

    $3,041,030
  • Website:

  • Email:

Related Drugs
Water-soluble vitamins for injection
The main ingredients of this product are multivitamins, and the components in each 1000 bottles are:
Name Description Content CAS NO. Registered Holders
Various vitamins

This product is a part of intravenous nutrition, used to supplement the daily physiological needs of various water-soluble vitamins so that the body's relevant biochemical reactions can proceed normally.

More

This product is a part of intravenous nutrition, used to supplement the daily physiological needs of various water-soluble vitamins so that the body's relevant biochemical reactions can proceed normally.

0
Huoxiang Qushu soft capsule
Patchouli, Elsholtzia, Angelica dahurica, Perilla leaf, Atractylodes lancea, Clove, Tangerine peel, Citrus grandis peel, Pinellia ternata, Poria cocos, Ginger, Licorice.
Name Description Content CAS NO. Registered Holders
POGOSTEMONIS HERBA

0
HERBA MOSLAE

0
Angelicae Dahuricae Radix

0
Folia perillae acutae

0
ATRACTYLODIS RHIZOMA

0
Clove oil

8000-34-8 4
Citri reticulatae pericarpium

0
Arecae Pericarpium

0
PinelliaTuber

0
Poria

0
Giner Oil

0
DGL

0
Carbazochrome Sodium Sulfonate for Injection
The main component of this product is carbazochrome sodium sulfonate. Its chemical name is 1-methyl-6-oxo-2,3,5,6-tetrahydroindole-5-semicarbazone-2-sulfonic acid sodium salt trihydrate. Molecular formula: C10H11N4NaO5S3H2O, molecular weight: 376.32
Name Description Content CAS NO. Registered Holders
Carbazochrome sodium sulfonate

This product can reduce capillary permeability, enhance the retraction effect of broken capillary ends, and increase the resistance of capillaries to damage. It is often used for various types of bleeding caused by increased capillary permeability.

More

This product can reduce capillary permeability, enhance the retraction effect of broken capillary ends, and increase the resistance of capillaries to damage. It is often used for various types of bleeding caused by increased capillary permeability.

51460-26-5 33
Lincomycin Hydrochloride Injection
The main ingredient is lincomycin hydrochloride, and its chemical name is 6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-6,8-dideoxy-D-erythro-alpha;-D-galacto-octinopyranoside hydrochloride hydrate. Its structural formula is: Molecular formula: C18H34N2O6SHClH2O Molecular weight: 461.02
Name Description Content CAS NO. Registered Holders
Lincomycin hydrochloride

It has high antibacterial activity against common aerobic Gram-positive bacteria, such as Staphylococcus aureus (including those resistant to penicillin G), Staphylococcus epidermidis, beta-hemolytic Streptococcus, viridans Streptococcus and Streptococcus pneumoniae. It has good antibacterial effect on anaerobic bacteria, including Clostridium diphtheriae, and Clostridium perfringens. It has no activity against Gram-negative bacteria such as Enterococcus, meningococci, Neisseria gonorrhoeae, and Haemophilus influenzae, as well as fungi. There is no cross-resistance between this product and penicillin, chloramphenicol, cephalosporins and tetracyclines, and there is partial cross-resistance with macrolides. This product acts on the 50S subunit of the ribosome of sensitive bacteria, preventing the extension of the peptide chain, thereby inhibiting the protein synthesis of bacterial cells. It is generally an antibacterial agent, but at high concentrations, it also has a bactericidal effect on certain bacteria.

More

It has high antibacterial activity against common aerobic Gram-positive bacteria, such as Staphylococcus aureus (including those resistant to penicillin G), Staphylococcus epidermidis, beta-hemolytic Streptococcus, viridans Streptococcus and Streptococcus pneumoniae. It has good antibacterial effect on anaerobic bacteria, including Clostridium diphtheriae, and Clostridium perfringens. It has no activity against Gram-negative bacteria such as Enterococcus, meningococci, Neisseria gonorrhoeae, and Haemophilus influenzae, as well as fungi. There is no cross-resistance between this product and penicillin, chloramphenicol, cephalosporins and tetracyclines, and there is partial cross-resistance with macrolides. This product acts on the 50S subunit of the ribosome of sensitive bacteria, preventing the extension of the peptide chain, thereby inhibiting the protein synthesis of bacterial cells. It is generally an antibacterial agent, but at high concentrations, it also has a bactericidal effect on certain bacteria.

859-18-7 30
Sodium pantothenate
The main ingredient of this product is levothyroxine sodium.
Name Description Content CAS NO. Registered Holders
Levothyroxine sodium

1. Increase the effect of anticoagulants; 2. Increase the level of phenytoin sodium in the blood; 3. The metabolism is accelerated by anticonvulsants such as carbamazepine and phenytoin sodium, and can be replaced from plasma proteins; 4. The dosage of cardiac glycosides needs to be adjusted when used with cardiac glycosides; 5. Increase the effect of sympathomimetic drugs; 6. Increase the sensitivity of catecholamine receptors, thereby enhancing the response of tricyclic antidepressants; 7. The absorption is reduced by the influence of cholestyramine, and the dosage needs to be increased when used in combination with oral contraceptives.

More

1. Increase the effect of anticoagulants; 2. Increase the level of phenytoin sodium in the blood; 3. The metabolism is accelerated by anticonvulsants such as carbamazepine and phenytoin sodium, and can be replaced from plasma proteins; 4. The dosage of cardiac glycosides needs to be adjusted when used with cardiac glycosides; 5. Increase the effect of sympathomimetic drugs; 6. Increase the sensitivity of catecholamine receptors, thereby enhancing the response of tricyclic antidepressants; 7. The absorption is reduced by the influence of cholestyramine, and the dosage needs to be increased when used in combination with oral contraceptives.

55-03-8 20
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.